Pancreatic Cancer Research

ResearcherSecond Military Medical UniversityNo recent work listed

Yunliang Sun

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5111629356. Sources: OpenAlex.

Their work

Papers
4 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper

Papers 4

  1. Triptolide enhances the sensitivity of pancreatic cancer PANC-1 cells to gemcitabine by inhibiting TLR4/NF-κB signaling. First author PMID 31312385↗
  2. Toll-like receptor 4 promotes angiogenesis in pancreatic cancer via PI3K/AKT signaling. Co-author DOI 10.1016/j.yexcr.2016.07.009↗
  3. Triptolide induces apoptosis and inhibits the growth and angiogenesis of human pancreatic cancer cells by downregulating COX-2 and VEGF. First author DOI 10.3727/096504013x13657689382932↗
  4. CEA promoter-regulated oncolytic adenovirus-mediated Hsp70 expression in immune gene therapy for pancreatic cancer. First author DOI 10.1016/j.canlet.2012.01.009↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jianxia Ma · 2 shared papers, 2016–2019 · strength 0.18
  2. Hongyu Wu · 2 shared papers, 2013–2019 · strength 0.16
  3. Xiaofeng Yu · 2 shared papers, 2013–2019 · strength 0.16
  4. Shu-De Li · 1 shared paper, 2016 · strength 0.07
  5. Hongyu Wu · 1 shared paper, 2016 · strength 0.07
  6. Jianxia Ma · 1 shared paper, 2013 · strength 0.04
  7. Can Xu · 1 shared paper, 2012 · strength 0.03
  8. Zhao‐Shen Li · 1 shared paper, 2012 · strength 0.03
  9. Changqing Su · 1 shared paper, 2012 · strength 0.03
  10. Yan Yan · 1 shared paper, 2012 · strength 0.03
  11. Maoling Zhu · 1 shared paper, 2012 · strength 0.03
  12. Lei Chen · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.